Probabilistic Measurement of Central Line-Associated Bloodstream Infections

Infection Control and Hospital Epidemiology

Volumn 37, Issue 2, 2016, Pages 149-155

  Hota, Bala ^a   Malpiedi, Paul ^b   Fridkin, Scott K ^b   Martin, John ^c   Trick, William ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Premier Research Institute   (United States)

^d Cook County Health and Hospitals System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CULTURE; CATHETER INFECTION; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; ADVERSE EFFECTS; BACTEREMIA; BENCHMARKING; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CROSS INFECTION; FACTUAL DATABASE; HOSPITAL SUBDIVISIONS AND COMPONENTS; INFECTION CONTROL; MICROBIOLOGY; MULTICENTER STUDY (TOPIC); PROCEDURES; REGRESSION ANALYSIS; UNITED STATES;

BACTEREMIA; BENCHMARKING; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; DATABASES, FACTUAL; HOSPITAL UNITS; HUMANS; INFECTION CONTROL; MULTICENTER STUDIES AS TOPIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84966431244     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.255     Document Type: Article

References (18)

1. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32:101-114.
2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-2732.
3. McKibben L, Horan TC, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 2005;26:580-587.
4. Pronovost PJ, Miller M, Wachter RM. The GAAP in quality measurement and reporting. JAMA 2007;298:1800-1802.
5. Passaretti CL, Barclay P, Pronovost P, Perl TM. Public reporting of health care-associated infections (HAIs): approach to choosing HAI measures. Infect Control Hosp Epidemiol 2011;32:768-774.
6. Panzer RJ, Gitomer RS, Greene WH, Webster PR, Landry KR, Riccobono CA. Increasing demands for quality measurement. JAMA 2013;310:1971-1980.
7. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304:2035-2041.
8. Mayer J, Greene T, Howell J, et al. Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis 2012;55:364-370.
9. McBryde ES, Brett J, Russo PL, Worth LJ, Bull AL, Richards MJ. Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia. Infect Control Hosp Epidemiol 2009;30:1045-1049.
10. Worth LJ, Brett J, Bull AL, McBryde ES, Russo PL, Richards MJ. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals. Am J Infect Control 2009;37:643-648.
11. DiGiorgio MJ, Fatica C, Oden M, et al. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol 2012;33:865-868.
12. Gaur AH, Bundy DG, Gao C, et al. Surveillance of hospitalacquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol 2013;34: 316-320.
13. Steinberg JP, Robichaux C, Tejedor SC, Reyes MD, Jacob JT. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol 2013;34:171-175.
14. Sexton DJ, Chen LF, Moehring R, Thacker PA, Anderson DJ. Casablanca redux: we are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate. Infect Control Hosp Epidemiol 2012;33:932-935.
15. Rakow T, Wright RJ, Spiegelhalter DJ, Bull C. The pros and cons of funnel plots as an aid to risk communication and patient decision making. Br J Psychol 2015;106:327-348.
16. Schulman J, Spiegelhalter DJ, Parry G. How to interpret your dot: decoding the message of clinical performance indicators. J Perinatol 2008;28:588-596.
17. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). CDC website. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC-CLABScurrent.pdf. Published January 2015. Updated April 2015. Accessed August 21, 2015.
18. Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31:1286-1289.